WG
CRL icon

Winton Group’s Charles River Laboratories CRL Stock Holding History

Winton Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,163
Closed -$9.21M – 1162
2025
Q4 		$9.21M Buy
+46,163
New +$8.37M 0.32% 80
2024
Q4 		– Sell
-29,121
Closed -$5.74M – 647
2024
Q3 		$5.74M Buy
29,121
+27,020
+1,286% +$5.62M 0.4% 65
2024
Q2 		$434K Buy
+2,101
New +$476K 0.03% 441
2021
Q2 		– Sell
-1,050
Closed -$304K – 1432
2021
Q1 		$304K Sell
1,050
-1,140
-52% -$317K 0.02% 1134
2020
Q4 		$547K Buy
+2,190
New +$522K 0.04% 750
2020
Q3 		– Sell
-5,328
Closed -$929K – 1492
2020
Q2 		$929K Sell
5,328
-16,014
-75% -$2.56M 0.02% 993
2020
Q1 		$2.69M Buy
+21,342
New +$3.2M 0.07% 466
2019
Q4 		– Sell
-23,211
Closed -$3.07M – 1585
2019
Q3 		$3.07M Sell
23,211
-41,046
-64% -$5.5M 0.04% 422
2019
Q2 		$9.12M Sell
64,257
-9,264
-13% -$1.26M 0.18% 179
2019
Q1 		$10.7M Sell
73,521
-14,433
-16% -$1.9M 0.21% 182
2018
Q4 		$9.96M Buy
87,954
+5,328
+6% +$667K 0.21% 207
2018
Q3 		$11.1M Buy
+82,626
New +$10.2M 0.23% 175
2018
Q2 		– Sell
-57,049
Closed -$6.09M – 1038
2018
Q1 		$6.09M Buy
57,049
+940
+2% +$101K 0.17% 180
2017
Q4 		$6.14M Sell
56,109
-108,443
-66% -$11.8M 0.18% 172
2017
Q3 		$17.8M Buy
164,552
+6,289
+4% +$646K 0.57% 43
2017
Q2 		$16M Buy
+158,263
New +$14.6M 0.47% 58
2015
Q1 		– Sell
-7,237
Closed -$461K – 434
2014
Q4 		$461K Sell
7,237
-12,888
-64% -$808K 0.01% 548
2014
Q3 		$1.2M Sell
20,125
-2,672
-12% -$153K 0.01% 502
2014
Q2 		$1.22M Buy
+22,797
New +$1.25M 0.01% 507

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winton Group's CRL Position: Q1 2026 in Review

Winton Group sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 46,163 shares — an estimated $9.21M sold.

Winton Group first reported a position in CRL in Q2 2014 and held it in 19 quarters. The position peaked at $17.8M in Q3 2017. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Winton Group reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Winton Group sold 46,163 Charles River Laboratories shares in Q1 2026, an estimated $9.21M.
  • Winton Group first reported a position in Charles River Laboratories in Q2 2014 and held it in 19 quarters.
  • Winton Group's Charles River Laboratories position peaked at $17.8M in Q3 2017.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.